These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25975176)

  • 21. Absence of germline epimutation of the CDKN2A gene in familial melanoma.
    van Doorn R; Zoutman WH; Gruis NA
    J Invest Dermatol; 2009 Mar; 129(3):781-4. PubMed ID: 18818678
    [No Abstract]   [Full Text] [Related]  

  • 22. CDKN2A as a uveal and cutaneous melanoma susceptibility gene.
    Kannengiesser C; Avril MF; Spatz A; Laud K; Lenoir GM; Bressac-de-Paillerets B
    Genes Chromosomes Cancer; 2003 Nov; 38(3):265-8. PubMed ID: 14506702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
    Bertolotto C; Lesueur F; Giuliano S; Strub T; de Lichy M; Bille K; Dessen P; d'Hayer B; Mohamdi H; Remenieras A; Maubec E; de la Fouchardière A; Molinié V; Vabres P; Dalle S; Poulalhon N; Martin-Denavit T; Thomas L; Andry-Benzaquen P; Dupin N; Boitier F; Rossi A; Perrot JL; Labeille B; Robert C; Escudier B; Caron O; Brugières L; Saule S; Gardie B; Gad S; Richard S; Couturier J; Teh BT; Ghiorzo P; Pastorino L; Puig S; Badenas C; Olsson H; Ingvar C; Rouleau E; Lidereau R; Bahadoran P; Vielh P; Corda E; Blanché H; Zelenika D; Galan P; ; Aubin F; Bachollet B; Becuwe C; Berthet P; Bignon YJ; Bonadona V; Bonafe JL; Bonnet-Dupeyron MN; Cambazard F; Chevrant-Breton J; Coupier I; Dalac S; Demange L; d'Incan M; Dugast C; Faivre L; Vincent-Fétita L; Gauthier-Villars M; Gilbert B; Grange F; Grob JJ; Humbert P; Janin N; Joly P; Kerob D; Lasset C; Leroux D; Levang J; Limacher JM; Livideanu C; Longy M; Lortholary A; Stoppa-Lyonnet D; Mansard S; Mansuy L; Marrou K; Matéus C; Maugard C; Meyer N; Nogues C; Souteyrand P; Venat-Bouvet L; Zattara H; Chaudru V; Lenoir GM; Lathrop M; Davidson I; Avril MF; Demenais F; Ballotti R; Bressac-de Paillerets B
    Nature; 2011 Oct; 480(7375):94-8. PubMed ID: 22012259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel CDKN2A mutation detected in Spanish melanoma pedigree.
    de Torre C; Martínez-Escribano J
    Exp Dermatol; 2010 Aug; 19(8):e333-5. PubMed ID: 20653773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
    Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation.
    Bassoli S; Pellegrini C; Longo C; Di Nardo L; Farnetani F; Cesinaro AM; Pellacani G; Fargnoli MC
    Melanoma Res; 2018 Apr; 28(2):166-169. PubMed ID: 29485552
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma].
    Avril MF; Bahadoran P; Cabaret O; Caron O; de la Fouchardière A; Demenais F; Desjardins L; Frébourg T; Hammel P; Leccia MT; Lesueur F; Mahé E; Martin L; Maubec E; Remenieras A; Richard S; Robert C; Soufir N; Stoppa-Lyonnet D; Thomas L; Vabres P; Bressac-de Paillerets B
    Ann Dermatol Venereol; 2015 Jan; 142(1):26-36. PubMed ID: 25600792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
    Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain.
    Nagore E; Montoro A; Oltra S; Ledesma E; Botella-Estrada R; Millán JM; Oliver V; Fortea JM; Guillén C
    Melanoma Res; 2005 Dec; 15(6):555-8. PubMed ID: 16314743
    [No Abstract]   [Full Text] [Related]  

  • 30. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
    Soufir N; Lacapere JJ; Bertrand G; Matichard E; Meziani R; Mirebeau D; Descamps V; Gérard B; Archimbaud A; Ollivaud L; Bouscarat F; Baccard M; Lanternier G; Saïag P; Lebbé C; Basset-Seguin N; Crickx B; Cave H; Grandchamp B
    Br J Cancer; 2004 Jan; 90(2):503-9. PubMed ID: 14735200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
    Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
    Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome.
    Gironi LC; Colombo E; Farinelli P; Giorgione R; Bozzola C; Ogliara P; Pasini B
    Int J Dermatol; 2015 Dec; 54(12):e553-5. PubMed ID: 26381259
    [No Abstract]   [Full Text] [Related]  

  • 33. MicroRNAs in the pathogenesis of malignant melanoma.
    Glud M; Gniadecki R
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):142-50. PubMed ID: 22621697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
    Soufir N; Basset-Seguin N
    Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
    Bergman W; Gruis NA
    Arch Dermatol; 2007 Apr; 143(4):525-6. PubMed ID: 17438187
    [No Abstract]   [Full Text] [Related]  

  • 36. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
    Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
    Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred.
    Yang G; Niendorf KB; Tsao H
    J Invest Dermatol; 2004 Sep; 123(3):574-5. PubMed ID: 15304098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic.
    Dika E; Patrizi A; Rossi C; Turchetti D; Miccoli S; Ferracin M; Veronesi G; Scarfì F; Lambertini M
    Ital J Dermatol Venerol; 2021 Oct; 156(5):599-605. PubMed ID: 32221274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes.
    De Simone P; Bottillo I; Valiante M; Iorio A; De Bernardo C; Majore S; D'Angelantonio D; Valentini T; Sperduti I; Piemonte P; Eibenschutz L; Ferrari A; Carbone A; Buccini P; Paiardini A; Silipo V; Frascione P; Grammatico P
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.